RESEARCH-USE BIOSIMILAR ANTIBODY
Pritumumab
Monoclonal antibody · IgG1
Pritumumab is a natural human IgG1kappa mAb originally isolated from a regional draining lymph node of a patient with cervical carcinoma. Pritumumab recognizes vimentin expressing on the cell surface of the malignant tumor. Pritumumab can be used for glioblastoma research.
TARGETVimentin
YMonoclonal antibody
CATALOGSC-BS-257
CATALOG NUMBERSC-BS-257
MOLECULAR WEIGHTApprox. 144.92 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Pritumumab is a natural human IgG1kappa mAb originally isolated from a regional draining lymph node of a patient with cervical carcinoma. Pritumumab recognizes vimentin expressing on the cell surface of the malignant tumor. Pritumumab can be used for glioblastoma research.
Pritumumab is a recombinant research-use antibody directed against Vimentin.